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Fragile X syndrome (FXS), caused by silencing of the Fmr1 gene, is
the most common form of inherited mental retardation. Epilepsy is
reported to occur in 20--25% of individuals with FXS. However, no
overall increased excitability has been reported in Fmr1 knockout
(KO) mice, except for increased sensitivity to auditory stimulation.
Here, we report that kindling increased the expressions of Fmr1
mRNA and protein in the forebrain of wild-type (WT) mice. Kindling
development was dramatically accelerated in Fmr1 KO mice, and
Fmr1 KO mice also displayed prolonged electrographic seizures
during kindling and more severe mossy ﬁber sprouting after
kindling. The accelerated rate of kindling was partially repressed by
inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-
801 or mGluR5 receptor with 2-methyl-6-(phenylethynyl)-pyridine
(MPEP). The rate of kindling development in WT was not effected
by MPEP, however, suggesting that FMRP normally suppresses
epileptogenic signaling downstream of metabolic glutamate
receptors. Our ﬁndings reveal that FMRP plays a critical role in
suppressing limbic epileptogenesis and predict that the enhanced
susceptibility of patients with FXS to epilepsy is a direct
consequence of the loss of an important homeostatic factor that
mitigates vulnerability to excessive neuronal excitation.
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Introduction
Fragile X syndrome (FXS), the most common form of inherited
mental retardation, results from a trinucleotide repeat (CGG)
expansion in the 5#-untranslated region of the gene Fmr1
(Verkerk et al. 1991). The CGG repeat expansion and
subsequent hypermethylation cause transcriptional silencing
of Fmr1 and loss of its encoded protein, the fragile X mental
retardation protein (FMRP) (O’Donnell and Warren 2002; Jin
and Warren 2003). Murine FMRP is a brain-speciﬁc RNA-
binding protein that suppresses translation of target RNAs.
Through interactions with kinesin, FMRP is able to travel
between distal neurites and the soma of neurons and thereby
regulate protein synthesis locally within speciﬁc cellular
compartments (Ashley et al. 1993; Warren and Nelson 1994;
Eberhart et al. 1996; Brown et al. 1998; Darnell et al. 2001; Li et al.
2001; Ohashi et al. 2002; Ling et al. 2004; Davidovic et al. 2007).
Patients with FXS exhibit mental retardation, attention
deﬁcits, autistic behavior, macroorchidism, and facial abnor-
malities (Turner et al. 1980; Opitz and Sutherland 1984;
Sobesky et al. 1996). Additionally, epilepsy is reported to occur
in 20--25% of individuals with FXS and paroxysmal electroen-
cephalography (EEG) abnormalities are present in about 50% of
prepubescent boys with FXS (Musumeci et al. 1999; Sabar-
atnam et al. 2001; Hagerman et al. 2002). These EEG pattern
abnormalities resemble those of patients with benign focal
epilepsy of childhood (Berry-Kravis 2002). FMRP deﬁciency is
speculated to lead to increased neuronal excitability and
susceptibility to seizures in humans. However, spontaneous
seizures are never observed in Fmr1 knockout (KO) mice and
sensitivity to convulsants (such as bicuculline, pentylenetetra-
zol and kainic acid) is not signiﬁcantly different from wild-type
(WT) mice (Chen and Toth 2001). The most substantial deﬁcit
observed in Fmr1 KO mice is increased sensitivity to auditory
seizures (Musumeci et al. 2000; Chen and Toth 2001),
suggesting that Fmr1 KO mice do not have an overall increased
excitability phenotype but rather auditory system speciﬁc
hyperexcitability.
Recent studies have challenged this conclusion. In hippo-
campal slices from Fmr1 KO mice, increasing neuronal activity
by blocking c-aminobutyric acidergic (GABAergic) transmis-
sion by the GABAA receptor antagonist bicuculline induces
prolonged epileptiform discharges (Chuang et al. 2005).
Furthermore, these prolonged discharges can be suppressed
with the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-
pyridine (MPEP). These observations suggest that FMRP
does inﬂuence neuronal excitability in the forebrain, possibly
by repressing group I mGluR-mediated RNA translation
(Chuang et al. 2005). Interestingly, MPEP could also reverse
other symptoms of Fmr1 KO mice, including sound-
induced seizures (Bear et al. 2004; Chuang et al. 2005;
McBride et al. 2005; Yan et al. 2005). These ﬁndings support
the mGluR theory of FXS (Bear et al. 2004; Ronesi and Huber
2008).
To investigate seizure susceptibility in the limbic system of
Fmr1 KO mice in vivo, we used a well-established animal
model of limbic epilepsy, amygdala kindling, to explore the role
of FMRP in limbic epileptogenesis. Kindling mimics epilepto-
genesis in which repeated administration of an initially
subconvulsive electrical stimulation of the amygdala results in
progressive intensiﬁcation of behavioral seizures and pro-
longation of electrographic afterdischarges (AD) (Goddard
et al. 1969; Racine 1972). We found that kindling stimulation
increased the expression of Fmr1 mRNA and protein in the
forebrain of WT mice. The development of behavioral seizures
was dramatically accelerated in the Fmr1 KO mice, and AD
durations were greatly exaggerated throughout kindling.
Furthermore, exuberant mossy ﬁber sprouting (MFS) was
observed in fully kindled Fmr1 KO mice. Behavioral seizures
could be repressed by administering the N-methyl-D-aspartic
acid receptor antagonist MK801 or mGluR5 antagonist MPEP in
Fmr1 KO mice. Interestingly, MPEP did not alter kindling
development in WT mice, suggesting that FMRP normally
suppresses the epileptogenic effects of mGluR5 activity. Our
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Materials and Methods
Experimental Animals
Male Fmr1 KO mice of the FVB strain (The Dutch--Belgian Fragile X
Consortium 1994) and their WT littermates were used. All animals were
maintained on a 12:12 h light:dark cycle with a constant room
temperature. Mice were group housed (3 to 4 per cage) and provided
with ad lib food and water. Kindling experiments were conducted
during the light phase of the cycle on 12-week-old adult mice. Mice
were handled according to the guidelines prescribed by the Animal
Care and Use Committee of the Institute of Neuroscience, Chinese
Academy of Sciences. All efforts were made to minimize suffering and
the number of animals used.
Drug Application
The NMDA antagonist MK801 (Sigma, St Louis, MO) and the mGluR5
antagonist MPEP (Tocris, Biotrend Chemikalien, Ko ¨ ln, Germany) were
dissolved in sterile saline (0.9% NaCl). Drugs were administered by
intraperitoneal injection (MK801, 0.5 mg/kg; MPEP, 30 mg/kg) 30 min
before each stimulation. Application of the transcription inhibitor
actinomycin D (Sigma) was performed on freely moving animals via
a cannula inserted into ventricle (coordinates: 3 mm lateral and 2.3 mm
posterior to bregma, 4 mm below dura) 30 min before a class 5 seizure--
inducing stimulation. Actinomycin D was dissolved in saline (0.9%
NaCl) to a ﬁnal concentration of 50 lg/ul. Actinomycin D 5 ll was
intracerebroventricular (i.c.v.) injected within 10 min.
Surgery and Kindling Procedure
A twisted bipolar electrode was implanted into the right amygdala
(coordinates: 2.9 mm lateral and 1.2 mm posterior to bregma, 4.6 mm
below dura) of animals under pentobarbital (60 mg/kg) anesthesia.
Animals were then given 10 days to recover. The electrographic seizure
threshold (EST) for each individual mouse was determined by applying
1-s train of 1-ms biphasic rectangular pulses at 60 Hz beginning at
50 lA. Additional stimulations increasing by 10 lA were administered at
2-min intervals until an electrographic seizure lasting at least 5 s was
evoked. Stimulations at the EST intensity were subsequently applied
once daily. EEGs and behavioral seizures were observed and recorded.
The severity of the behavioral manifestations of seizures was classiﬁed
according to the criteria of Racine (1972). Fully kindled is deﬁned by
the occurrence of 3 consecutive seizures of class 4 or greater. All
surgery and kindling procedures were performed blind to genotype.
Unstimulated control animals of each genotype underwent surgical
implantation of an electrode in the amygdala and were handled
identically but were not stimulated. Electrode placement was
conﬁrmed by methyl green pyronine-Y staining. Data derived from
animals with correct electrode placement were analyzed.
RNA Extraction, cDNA Synthesis, Reverse Transcription
Polymerase Chain Reaction, and Real-Time Polymerase Chain
Reaction
Two weeks after being fully kindled, WT mice were killed either 3 h
after a single class 5 seizure or without any further stimulation.
Forebrains of unstimulated and stimulated fully kindled mice were
dissected out and homogenized in a Trizol solution (100 mg of tissue/
ml; Invitrogen, Carlsbad, CA). Samples were incubated for 5 min at
room temperature before RNA extraction with chloroform for 3 min.
After centrifugation at 12 000 3 g for 15 min at 4 C, the aqueous phase
was transferred to a new tube, and total RNA was precipitated with
isopropanol at –20 C for a minimum of 1 h. RNA was washed in 75%
ethanol, dissolved in nuclease-free water to a ﬁnal concentration of
1 mg/ml, and stored at –80 C.
First-strand cDNA was synthesized by priming 2 lg of total RNA with
an oligo-dT primer and extending with M-MLV reverse transcriptase
(Invitrogen) in a 20-ll reaction at 37 C for 60 min. Products were then
diluted into 100 ll. Four microliters of ﬁrst-strand cDNA preparation
were used as template in polymerase chain reaction (PCR) reactions
with the following sense and antisense oligonucleotide primers: 1) P1
(5#-CTCAAAGCGAGCCCACAT) and P2 (5#-TACCATACCCTGCCAAGC),
these primers direct the ampliﬁcation of nucleotide 793 to 1456
of mouse Fmr1 cDNA and 2) P3 (5#-CTGCCCAGAACATCATCCCT) and
P4 (5#-CCACCACCCTGTTGC TGTAG), these primers direct the
ampliﬁcation of nucleotide 579 to 947 of mouse Gapdh cDNA. The
cDNA was ampliﬁed with Taq polymerase under the following PCR
conditions; for Fmr1: 28 cycles of denaturation at 94 C for 30 s,
annealing at 55 C for 30 s, and extension at 72 C for 1 min and for
Gapdh: 20 cycles of 94 C for 30 s, 60 C for 30 s, and 72 C for 1 min.
PCR products were analyzed in 1% agarose gels.
Real-time PCR analysis of Fmr1 expression was performed using SYBR
Green I in a 20-ll reaction with an ABI Prism 7000 thermocycler (Applied
Biosystems,FosterCity,CA).PrimersusedfortheampliﬁcationofFmr1were
P5 (5#-GTGGTTA GCTAAAGTGAGGATGAT) and P6 (5#-CAGGTTTGT-
TGGGATTAACAGATC). Primers used to amplify Gapdh were the same as
those listed above (P3 and P4). Products were ampliﬁed with HotStart
ExTaqDNA polymerase under the following PCR conditions: denaturation
at 95 C for 5 min followed by 45 cycles of 10 s at 95 Ca n d3 1sa t6 0C.
Dissociation curve analysis was performed after ampliﬁcation to conﬁrm
the absence of nonspeciﬁc ampliﬁcation products and primer--dimers.
Real-time PCR results were analyzed with ABI Prism SDS 7000 software
(Applied Biosystems).
In Situ Hybridization
Two weeks after being fully kindled, WT mice were perfused trans-
cardially for 10 min with 4% paraformaldehyde in 0.1 M phosphate buffer
(PB, pH 7.4) either 3 h after a single class 5 seizure or without any further
stimulation. Brains were removed and postﬁxed in the same ﬁxative for
4 h at 4 C. After postﬁxation, brains were immersed in 20% sucrose in PB
overnight at 4 C. Coronal cryostat sections (20 lm) were mounted onto
Fisher Super Frost Microscope slides and stored at –80 C.
Antisense probes against Fmr1 nucleotides 1126--1670 were
designed. Reverse transcription polymerase chain reaction (RT-PCR)
products were subcloned into pEGM-T-Easy vector (Promega, Madison,
WI) and digoxigenin (DIG)-labeled sense and antisense ribonucleotide
probes were generated by in vitro transcription using T7 and Sp6 RNA
polymerases. Slides were prehybridized in hybridization buffer for 4 h
at 65 C and then hybridized with probes (1 lg/ml) in hybridization
buffer at 65 C overnight. After extensive washing, slides were
incubated with preabsorbed alkaline phosphatase--conjugated anti-
DIG antibody (Roche, Switzerland) at 4 C overnight. Signals were
developed by nitrotetrazolium blue-5-bromo-4-chloro-3-indolyl phos-
phate color reaction in the dark for 6--8 h. Samples were analyzed under
a Nikon E600FN upright microscope.
Western Blot
Frozen forebrains extracted at the time points described in the
Results section were thawed on ice and homogenized in lyses buffer
containing 50 mM Tris-HCl (pH 7.4), 20 lg/ml leupeptin, 20 lg/ml
aprotinin, 0.1 mM phenylmethylsulfonyl ﬂuoride, 1 mM EDTA, 1 mM
sodium orthovanadate, 1.0% deoxycholate. The homogenate was
incubated on ice for 30 min to allow complete lyses and then
centrifuged for 20 min at 14 000 3 g (4 C) to remove nuclear
fractions, and protein concentrations were then determined using the
bicinchoninic acid kit (BCA kit; Pierce, Rockford, IL). Proteins were
separated by 9% sodium dodecyl sulfate--polyacrylamide gel and
transferred to nitrocellulose membranes with a transblot semi-dry
apparatus (Bio-Rad, Hercules, CA). Membranes were blocked in Tris-
Buffered Saline Tween-20 (TBST; 0.05% Tween-20 in TBS) containing
5% dehydrated fat-free milk for 1 h and then incubated with anti-
FMRP monoclonal antibody 1C3 (1:500; Chemicon, Temecula, CA) or
anti-Glyceraldehyde 3-phosphate dehydrogenase monoclonal anti-
body (1:5000, KangChen, Shanghai, China) at 4 C overnight. Mem-
branes were washed in TBST buffer and incubated for 1 h with
horseradish peroxidase--conjugated goat anti-mouse secondary anti-
body (1:5000, Chemicon) at room temperature. Immunoblots were
developed with enhanced chemiluminescence (Pierce). Quantitative
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Dynamics, Sunnyvale, CA).
Immunohistochemistry
Free-ﬂoating sections were treated in 1% H2O2 for 30 min at room
temperature and incubated for 5 min in 0.5% Triton X-100, washed in
phosphate-bufferedsaline(PBS),andblockedwith 5% NGSinPBS for1h
at room temperature. Slices were then incubatedwith anti-FMRP(1:200;
Chemicon) overnight at 4 C, washed, and incubated with biotinylated
goat anti-mouse IgG (1:200; Boster, Wuhan, China) for 1 h at room
temperature. After being washed with PBS, slices were reacted with
peroxidase-conjugated avidin--biotin complexes (Vector, Burlingame,
CA; 1 h)for 1h at roomtemperature. Signals were developed with 0.03%
3,3-diaminobenzidine tetrahydrochloride dihydrate (Sigma) in 50 mM
Tris buffer containing 0.003% H2O2, pH 7.6. Negative control sections
were prepared by omitting primary antibodies. Samples were analyzed
under a Nikon E600FN upright microscope.
The Fluoro-Jade B Staining
For cell death analyses, both kindled WT and Fmr1 KO mice were
sacriﬁced 24 h after being fully kindled. WT and Fmr1 KO brain
sections were prepared as described in the In Situ Hybridization.
Mounted sections were rehydrated in an ethanol series (3 min 100%
ethanol, 1 min 70% ethanol, 1 min 50% ethanol, and 1 min distilled
water) and then incubated in a solution of 0.06% potassium
permanganate for 10 min on a rotating platform, rinsed in distilled
water for 2 min, and transferred to ﬂuoro-jade B (FJB) staining solution
(0.0004% FJB in 0.1% acetic acid, prepared 10 min before use) for 20
min. Labeled sections were imaged with a confocal laser-scanning
microscope (Olympus LSM-GB200) under green (FJB) ﬂuorescence.
Staining and data analysis were done by an individual blinded to the
genotype and treatment.
Timm Staining
Fully kindled WT and Fmr1 KO mice were killed either 5 or 28 weeks
later after the last stimulation. Mice were perfused transcardially with
saline for 2 min, followed by 0.16% sodium sulﬁde in PB for 4 min, and
followed by saline for 1 min and 4% paraformaldehyde in PB for 10 min.
Brains were then removed and postﬁxed overnight at 4 C and
immersed in 20% sucrose at 4 C the following night. Horizontal
sections (20 lm) were collected in PBS (pH 7.4) and mounted onto
gelatin-coated slides and developed in the dark at room temperature
for 30--50 min in a 12:6:2:1 mixture of gum arabic (50% w/v),
hydroquinone solution (5.67% w/v), citric acid--sodium citrate buffer
(26% citric acid w/v; 24% sodium citrate, w/v), and silver nitrate (17%
w/v). After washing thoroughly with running water, sections were
dehydrated, cleared in xylene, and coverslipped.
To assess MFS, the Timm index was measured using Image-Pro Plus
5.0 software (Media Cybernetics, Bethesda, MD) by dividing the total
area of Timm granules by total length of dentate gyrus (DG; Watanabe
et al. 1996). The Timm index of each mouse was calculated as the mean
value of 3 serial sections through the hippocampus of each animal.
Nissl Staining and Cell Number Counting
Cell death was assessed in serial horizontal sections (20 lm) through
the hippocampus. Every third slice between 4000 and 5300 lm
ventral from the dorsal surface of neocortex were placed into 1:1
alcohol:chloroform for 30 min and then rehydrated in an ethanol
series (3 min each in 100%, 95%, 80%, 70%, 60%, 50%, and 0% ethanol
in distilled water). Rehydrated slices were stained in cresyl violet
solution for 30 min at room temperature then dehydrated (3 min each
in 50%, 60%, 70%, 80%, 95%, and 100% ethanol), cleared in xylene and
mounted with resinous medium, and analyzed under a Nikon E600FN
upright microscope. Cells in the hilus ﬁeld were counted using Image-
Pro Plus 5.0 software (Media Cybernetics).
Statistical Analysis
Statistical analyses were carried out with GraphPad Prism Software (San
Diego, CA). For statistical analyses of kindling development, Timm
indices, and cell number, analyzers were blinded to the genotypes and
treatment. Kindling development data and real-time PCR result were
compared with unpaired t-test analysis, Timm indices were compared
with 2-way ANOVA,post hocBonferroni’s test.Cellnumberand western
blots were compared with 1-way ANOVA, post hoc Dunnett’s test.
Results
The Expressions of Fmr1 mRNA and FMRP are
Upregulated by Seizure Activity
Previous studies have demonstrated that the expression of
FMRP can be regulated by synaptic activity and experience
(Weiler et al. 1997; Todd and Mack 2000; Todd et al. 2003;
Gabel et al. 2004; Hou et al. 2006). To examine whether seizure
activity regulates Fmr1 transcription, we investigated the level
of Fmr1 mRNA expression after kindling-induced seizures (see
Materials and Methods for a description of kindling proce-
dures) by RT-PCR, real-time PCR, and in situ hybridization. Two
weeks after being fully kindled, WT mice were killed either 3 h
after a single stimulation, which was given to trigger a class 5
seizure, or without any further stimulation. RT-PCR and real-
time PCR were performed using RNA from the forebrain of
both unstimulated kindled WT mice and stimulated kindled WT
mice. As shown in Figure 1A, the level of Fmr1 mRNA in the
forebrain normalized to Gapdh increased signiﬁcantly 3 h after
kindling-induced seizure. Real-time PCR analysis showed that
a single class 5 seizure caused a 2-fold increase of Fmr1 mRNA
(n = 8) relative to unstimulated kindled mice (n = 8, P < 0.05).
In situ hybridization revealed that Fmr1 expression was
strongly induced in the cortex from low baseline levels 3 h
after seizure activity. Fmr1 expression was also upregulated in
the hippocampal CA1 region and DG, albeit to a lesser degree
and from a higher baseline (Fig. 1B). All changes in Fmr1 mRNA
expression after kindling stimulations were bilateral with no
hemispheric bias. No difference in Fmr1 mRNA expression was
observed between unstimulated fully kindled WT mice and
unkindled, sham-stimulated controls (data not shown).
We next examined if the upregulation of Fmr1 mRNA by
seizure activity resulted in a corresponding increase in protein
expression. Total protein lysates from individual forebrains
were assayed by western blot. The mean level of FMRP
normalized to Gapdh in the forebrain of unstimulated fully
kindled mice was essentially identical to that of unkindled
controls (data not shown). As shown in Figure 2A, FMRP
expression increased about 5-fold 3 h after class 5 seizure
activity in kindled mice (n = 8) relative to unstimulated fully
kindled mice (n = 12, P < 0.01), before declined back to
baseline levels by 12 h (Fig. 2B).
To investigate the spatial distribution of seizure-induced FMRP
expression, we performed immunohistochemical staining on
hippocampal sections. In unstimulated fully kindled mice, FMRP
was primarily expressed in the soma of CA1 pyramidal neurons
and DG granule cells, similar to unkindled controls (Fig. 2C and
data not shown). However, 3 h after a single class 5 seizure, the
intensity of FMRP immunostaining was greatly increased in
the soma of CA1 pyramidal neurons and in the soma of DG
granule cells (Fig. 2C, right panel). No obvious immunostaining
of either the dendrites or the nucleus of neurons in the
hippocampus was observed in control or stimulated animals.
To investigate whether the expression of FMRP correlates
with the development of kindling, we examined the expression
of FMRP at different stages during kindling development.
Protein lysates from the forebrain were extracted 3 h after the
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duration, 8.1 ± 0.5 s), 3 h after the ﬁrst class 2 seizure (5 ± 1
stimulations; AD duration of class 2 seizure, 19.2 ± 2.7 s), or 3 h
after the third consecutive class 4/5 seizure (12 ± 1
stimulations; AD duration of ﬁnal class 4/5 seizure, 26.9 ±
2.2 s). Relative to sham-stimulated controls, no increase in
FMRP was observed 3 h after the initial subconvulsive
stimulation (data not shown), but FMRP expression in the
forebrain signiﬁcantly increased after the ﬁrst class 2 seizure
and was further enhanced after full kindling (Fig. 2D).
Statistical analysis showed about a 3.5-fold increase of FMRP
expression after class 2 seizure (n = 5) and 5.2-fold increase of
FMRP expression in fully kindled mice (n = 8) compared with
controls (n = 17; P < 0.05 and P < 0.001, respectively) (Fig. 2E).
Taken together, these data reveal that both mRNA and protein
expression of Fmr1 gene are upregulated by kindling-induced
seizure activity in vivo.
Finally, in order to decipher the transcriptional versus
translational mechanisms of the seizure-induced upregulation
of FMRP, we i.c.v. injected the transcription inhibitor actino-
mycin D 30 min before a class 5 seizure-inducing stimulation
and then assayed Fmr1 mRNA or protein levels in the forebrain
3 h after by RT-PCR or western blotting. Actinomycin D did
block the seizure-induced increase in the level of Fmr1 mRNA
(n = 3; P < 0.05; Fig. 2F), but the increase in protein level was
unaffected (Fig. 2G). This data suggests that seizure activity-
induced upregulation of FMRP protein in WT mice is largely
due to changes in the rate of translation.
Accelerated Development of Kindling in Fmr1 KO Mice
To study the functional signiﬁcance of seizure-regulated FMRP
expression, seizure behaviors and AD durations of WT and Fmr1
KO mice after daily amygdala stimulations were compared.
There was no signiﬁcant difference in EST between the 2 groups
(Fig. 3A). The mean EST for WT and Fmr1 KO mice were 141.4±
9.77 lA( n = 25) and 139.7 ± 10.71 lA( n = 31), respectively.
Once-daily stimulation of the amygdala resulted in progressive
increase in the intensity of behavioral seizures in Fmr1 KO mice
as in WT mice. However, the rate at which behavioral seizures
progressed was dramatically accelerated in Fmr1 KO mice
(Fig. 3B) with the number of stimulations required to induce
3 consecutive class 4/5 seizures (5.45 ± 0.40, n = 25) reduced to
about half of the number of stimulations required for WT mice
(11.5 4 ± 0.45, n = 31, P < 0.001) (Fig. 3C).
The differences in behavioral seizure intensity were paral-
leled by differences in electrophysiological measures of seizure
duration. Fmr1 KO mice displayed prolonged AD after
repeated kindling stimulations (Fig. 4). By the third day of
stimulation, the AD duration was doubled compared with that
of WT mice (Fig. 4A). In WT mice, the duration of AD reached
about 30 s by the 14th stimulation and additional stimulation
did not induce any further prolongation of AD duration. In
sharp contrast, the AD duration reached 30 s after only 3
stimulations in Fmr1 KO mice and climbed up to over 45 s by
the 14th stimulation (Fig. 4A). Representative electrographs are
shown in Figure 4B.
Effects of NMDA Receptor and mGluR5 Antagonists on
Epileptogenesis
Studies of several animal models have shown that activation of
ionotropic (Croucher et al. 1995) and metabotropic glutamate
receptors (Wong et al. 1999) can promote epileptogenesis. We
speculated that FMRP might function to suppress seizure-
promoting actions of either one or both classes of glutamate
receptors. To test this, we treated Fmr1 KO mice with the
Figure 1. Kindling upregulates Fmr1 mRNA in the forebrain. (A) Quantitative real-
time PCR (lower) and RT-PCR (upper) analysis of Fmr1 mRNA expression. Total RNA
was isolated from forebrains of fully kindled WT mice 3 h after an evoked class 5
seizure (Stim.) or without any further stimulation (Unstim.). Fmr1 mRNA was
normalized to Gapdh mRNA levels and mean ± standard error of the mean values are
presented as a percentage of unstimulated controls; *P \ 0.05, unpaired t-test. (B)
Fmr1 in situ hybridization of coronal sections from unstimulated fully kindled WT mice
(left panel) and fully kindled WT mice 3 h after seizure (right panel). In the
unstimulated group, Fmr1 expression is relatively low in the cortex (a), the CA1 and
the DG (b and c). Three hours after a class 5 seizure, Fmr1 mRNA is upregulated in
both the cortex (d) and hippocampus (e and f). Lower panels show higher
magniﬁcation images of the areas indicated by the boxes in the upper panels. Scale
bars: upper panel, 400 lm in upper panel; lower panel, 50 lm.
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or the metabolic glutamate receptor mGluR5 antagonist MPEP.
Consistentwithpreviousstudies(McNamaraetal.1988;Satoetal.
1988; Lo ¨ scher and Ho ¨ nack1991), the rateofkindling inWTmice
was slowed down during the ﬁrst 2 weeks of stimulation when
MK801 was injected30min beforeeachdaily stimulation relative
tocontrolsinjectedwithsaline(Fig.5A).Interestingly,fortheﬁrst
9 daysofstimulation,the acceleration of kindlingdevelopment in
Fmr1 KO mice was also suppressed by MK801 (Fig. 5B). During
this period, there was no signiﬁcant difference in the average
seizure class between MK801 treated WT mice (n = 13) and
MK801 treated Fmr1 KO mice (n = 13). After the 10th
stimulation, kindling development in MK801-treated Fmr1 KO
micedramaticallyaccelerated comparedwiththeMK801-treated
WT mice. These observations implicate the involvement of
NMDARsinthe progression of kindlinginbothWT and Fmr1 KO
mice, and FMRP ablation does not obviously alter the suppressive
effect of inhibiting NMDAR on kindling development.
Figure 2. FMRP expression is upregulated after seizure activity. (A) Representative western blot showing a transient increase of FMRP in the forebrain of kindled mice after an
evoked seizure. Two weeks after fully kindling, a single class 5 seizure was induced in WT mice and forebrains were isolated 3 h or 12 h later. Each lane was loaded with an equal
amount of protein extract from a single forebrain sample (mouse #1--6). Lane 1 and 2, unstimulated fully kindled WT mice; lane 3 and 4, fully kindled mice 3 h after a class 5
seizure; lane 5 and 6, fully kindled mice 12 h after a class 5 seizure. After a class 5 seizure, FMRP expression increases before returning to baseline levels by 12 h. (B) Quantitative
analysis of western blot band intensities. FMRP immunoreactivity was normalized to Gapdh immunoreactivity and mean ± standard error of the mean (SEM) values are presented
as a percentage of the mean level in unstimulated fully kindled mice; *P\0.05; **P\0.01; ***P\0.001; 1-way ANOVA followed by post hoc Dunnett’s test. (C) Seizure
activity leads to increased FMRP expression in the soma of CA1 pyramidal cells and granule cells in the DG. Coronal sections through the hippocampus of unstimulated fully
kindled WT mice (left panel) and fully kindled WT mice 3 h after a class 5 seizure-inducing stimulation (right panel) were immunolabeled with anti-FMRP. Lower panels show
higher magniﬁcation of upper panel, note that no staining is observed in neurites and nucleus of hippocampal neurons. Scale bars: 400 lm for upper 1 row; 100 lm for lower 2
rows. (D) Upregulation of FMRP correlates with kindling development. Forebrains of WT mice isolated 3 h after sham stimulation (lane 1), 3 h after the ﬁrst class 2 seizure during
kindling (lane 2), or 3 h after the third class 5 seizure during kindling (lane 3). (E) Quantitative analysis of FMRP expression in (D). FMRP levels were normalized to Gapdh and
mean ± SEM values are presented as a percentage of the mean level in sham-stimulated mice; *P\0.05; **P\0.01; ***P\0.001; 1-way ANOVA with post hoc Dunnett’s
test. (F) Real-time PCR of Fmr1 RNA from control mice, saline-treated stimulated mice, actinomycin D-treated stimulated mice. Fmr1 transcript levels were upregulated at 3 h
after stimulation in saline-treated mice and application of actinomycin D 30 min before stimulation repressed the increase of Fmr1. Gapdh transcript levels were used to normalize
the levels of Fmr1 and values are presented as group mean ± SEM as a percentage of unstimulated samples; *P \ 0.05; 1-way ANOVA, post hoc Dunnett’s test. (G)
Representative western blot showing that application of actinomycin D did not obviously repress seizure-induced increases of FMRP.
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before each daily stimulation did not signiﬁcantly affect the
development of kindling (Fig. 6A), consistent with previous
study (Nagaraja et al. 2004). There was no signiﬁcant difference
in the average seizure class between the saline-treated WT
mice (n = 25) and MPEP-treated WT mice (n = 15) at any time
point throughout kindling (Fig. 6A). In contrast, application of
MPEP signiﬁcantly decelerated the rate of kindling progression
in Fmr1 KO mice up to the ninth day of stimulation. The
average seizure class from the fourth through to the eighth
stimulation point in MPEP-treated Fmr1 KO mice (n = 13) was
signiﬁcantly lower than saline-treated Fmr1 KO mice (n = 31)
(Fig. 6B). Together, this data suggests that FMRP normally
suppresses epileptogenic mGluR5 signal transduction and this
activity is disinhibited in Fmr1 KO mice, thus accelerating
kindling development.
Figure 3. Striking acceleration of kindling development in Fmr1 KO mice. (A)N o
signiﬁcant difference between WT and Fmr1 KO in mean EST is observed; P 5 0.77,
unpaired t-test. (B) Behavioral seizure intensities (class 1--5) evoked by amygdala
stimulation at the predetermined EST, presented as mean ± SEM of WT mice (n 5
25) and Fmr1 KO mice (n 5 31). (C) Number of stimulations required to provoke the
ﬁrst episode of class 4/5 seizure and third consecutive episode of class 4/5 seizure in
WT mice (n 5 25) and Fmr1 KO mice (n 5 31) mice; ***P \ 0.001; 2-tailed
unpaired t-test.
Figure 4. Fmr1 KO mice exhibit prolonged electrographic seizures. (A) AD durations
evoked by amygdala stimulation at the predetermined EST. The progressive
prolongation of AD durations was signiﬁcantly accelerated in Fmr1 KO mice compared
with WT mice. Data presented as mean ± standard error of the mean of WT mice
(n 5 25) and Fmr1 KO mice (n 5 31). (B) Representative EEG recordings of WT and
Fmr1 KO mice at the third stimulation, ﬁrst class 5 seizure-inducing stimulation and
third consecutive class 5 seizure-inducing stimulation. Arrows indicate the application
of stimulation, and the arrowheads indicate the termination point of the
electrographic seizure.
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MFS, characterized by an abnormal projection of the axon
collaterals of granule cells into the inner molecular layer (IML)
of the DG of the hippocampus (Sutula et al. 1989), is a feature
of neuronal circuit reorganization associated with limbic
epilepsy. We examined axon projections of hippocampal
granule cells by Timm staining of WT and Fmr1 KO mice, 5
weeks or 28 weeks after 22 consecutive days of stimulation.
Representative Timm-stained hippocampal sections from both
kindled and age-matched, sham-stimulated WT and Fmr1 KO
mice are shown in Figure 7A. The innervation’s pattern in
sham-stimulated Fmr1 KO mice (n = 13) was not obviously
different from that in sham-stimulated WT mice (n = 8)
(Fig. 7A, d vs. a and j vs. g; Fig. 7B). Interestingly, striking
enhancement of MFS in the IML was observed 5 weeks after 22
daily stimulations in the fully kindled Fmr1 KO mice, but no
change was observed in fully kindled WT mice (Fig. 7A, e vs. b,
k vs. h; Fig. 7B). Twenty-eight weeks after 22 daily stimulations,
a slight increase of Timm staining in the IML was detected in
WT kindled mice (Fig. 7A, i vs. g; Fig. 7B) but was less severe
than that in Fmr1 KO mice 5 weeks after stimulation. At the
28 week time point, MFS in fully kindled Fmr1 KO mice was
further enhanced (Fig. 7A, l vs. k). Statistical analyses revealed
a 10-fold increase of Timm index in the IML of the DG in the 5
weeks later killed fully kindled Fmr1 KO mice and a 40-fold
increase in 28 weeks later killed fully kindled Fmr1 KO mice
compared with their age-matched fully kindled WT mice
(Fig. 7B). The enhancement of Timm staining after kindling in
Fmr1 KO mice was selective to the IML region. To determine
whether the enhanced MFS in Fmr1 KO mice was accompa-
nied with an increase in neuronal cell loss, we performed
Fluoro-Jade B staining and Nissl staining (Fig. 8) of brain
sections from kindled mice. No obvious neuronal degeneration
was detected in either fully kindled WT or Fmr1 KO mice.
Discussion
Four principal ﬁndings emerged from this study. First, kindling
induced by repeated electrical stimulations of the amygdala
resulted in upregulation of the Fmr1 gene in the forebrain.
Second, the development of kindling, as measured by behav-
ioral and electrophysiological indices, was accelerated in Fmr1
KO mice. Third, inhibiting NMDAR slowed the early
Figure 5. Effects of the NMDA antagonist MK801 on kindling development in WT
and Fmr1 KO mice. (A) Behavioral seizure intensities evoked by amygdala stimulation
at the predetermined EST, data presented as mean ± standard error of the mean
(SEM) of saline-treated WT (n 5 25) and MK801-treated WT mice (n 5 13). (B)
Behavioral seizure intensities evoked by amygdala stimulation at the predetermined
EST, data presented as mean ± SEM of saline-treated (n 5 31) and MK801-treated
Fmr1 KO mice (n 5 13). MK801 signiﬁcantly slowed kindling development in both WT
mice and Fmr1 KO mice. Saline or MK801 was administered 30 min before each
stimulation. Asterisks indicate statistically signiﬁcant differences in the average
behavior seizure class at the indicated time point between the 2 presented groups.
*P \ 0.05; **P \ 0.01; ***P \ 0.001; 2-tailed unpaired t-test.
Figure 6. Effects of the mGluR5 antagonist MPEP on kindling development in WT
and Fmr1 KO mice. (A) Behavioral seizure class evoked by amygdala stimulation at
the predetermined EST, data presented as mean ± standard error of the mean (SEM)
of saline-treated (n 5 25) and MPEP-treated WT mice (n 5 15). There is no
signiﬁcant difference between kindling development in WT mice treated with MPEP
compared with controls. (B) Behavioral seizure class evoked by amygdala stimulation
at the predetermined EST, data presented as mean ± SEM of saline-treated (n 5 31)
and MPEP-treated Fmr1 KO mice treated (n 5 13). Administering MPEP to Fmr1 KO
mice signiﬁcantly represses seizure intensities at the fourth through eighth stimulation
point. Saline or MK801 was administered 30 min before each stimulation. Asterisks
indicate statistically signiﬁcant differences in the average behavior seizure class at the
indicated time point between the 2 presented groups. *P \ 0.05; **P \ 0.01;
***P \ 0.001; 2-tailed unpaired t-test.
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mice. By contrast, inhibiting mGluR5 partially repressed the
development of kindling in Fmr1 KO mice but had little effect
on kindling development in WT mice. Forth, kindling-induced
MFS into the IML region of the DG was dramatically enhanced
in Fmr1 KO mice.
FMRP is upregulated in response to neuronal activity
(Weiler et al. 1997; Todd and Mack 2000; Todd et al. 2003;
Figure 7. Axon projections of granule cells in the hippocampus of sham-stimulated
and fully kindled WT and Fmr1 KO mice. (A) Representative Timm staining of horizontal
brain sections of sham-stimulated (sham) WT mice (a, g); sham Fmr1 KO mice (d, j);
fully kindled (kindled) WT mice 5 weeks (b, h) or 28 weeks (c, i) after 22 daily
stimulation; kindled Fmr1 KO mice 5 weeks (e, k) or 28 weeks (f, l) after 22 daily
stimulations.Undercontrolconditions(sham),Fmr1KOmiceshowslightlymoreTimm-
stained granules in the granule cell body layer compared with WT mice. Five weeks
after 22 daily stimulations, MFS is obvious in the IML of the DG in Fmr1 KO mice.
Twenty-eight weeks after 22 daily stimulations, MFS is dramatically more severe in
Fmr1 KO mice. In contrast, WT mice show little MFS 28 weeks after 22 daily
stimulations.Scalebars:upper2panels,250lm;lower2panels,50lm.(B)Statistical
analysis of Timm index in the IML of the DG. Bars represent mean ± standard error of
the mean. ***P\0.001; 2-way ANOVA with post hoc Bonferroni’s test.
Figure 8. Fluoro-Jade B and Nissl staining reveal no obvious neuronal cell loss in
Fmr1 KO mice after kindling. (A) Fluoro-Jade B staining. A WT hippocampal section
24 h after pilocarpine-induced seizure (340 mg/kg, intraperitoneally) with signiﬁcant
cell death in the hilus of the DG is shown as a positive control (n 5 3). No cell death
is detected in sections from sham WT (n 5 3), kindled WT (n 5 6), or kindled Fmr1
KO (n 5 6) mice 24 h after the third consecutive class 5 seizure. Scale bar: 400 lm.
(B) Nissl staining. Nissl-stained brain sections from sham WT mice, kindled WT mice,
sham Fmr1 KO mice, and kindled Fmr1 KO mice reveal similar cell densities in the
CA1, CA3, cortex, and hilus of the DG. Scale bars: top, 500 lm for upper one row;
bottom, 250 lm for other rows. (C) Statistical analysis of cell number in the hilus. No
signiﬁcant difference was found among the 4 groups. Bars represent mean ±
standard error of the mean; 1-way ANOVA, post hoc Dunnett’s test.
Cerebral Cortex July 2009, V 19 N 7 1511Gabel et al. 2004; Irwin et al. 2005; Hou et al. 2006) and plays
an important role in synaptic plasticity by regulating the
translation, subcellular localization, and stability of speciﬁc
mRNA targets (Brown et al. 2001; Darnell et al. 2001; Zhang
et al. 2001; Miyashiro et al. 2003; Zalfa et al. 2003; Antar et al.
2004). Although FMRP can be translocated to distal compart-
ments of neurons and regulate local translation of target
mRNA, we observed increased FMRP immunoreactivity only
in the cell body of CA1 and DG cells after seizure activity
and did not detect FMRP within the neurites or nucleus of
these cells.
Several ﬁndings have pointed a role for both ionotropic
(Croucher et al. 1995) and metabotropic (Wong et al. 1999)
glutamate receptors in promoting seizure activity in various
animal models of epilepsy. To test the involvement of glutamate
receptors in the expedited development of kindling, we
treated Fmr1 KO mice with the NMDA receptor antagonist
MK801 or the mGluR5 antagonist MPEP. The loss of Fmr1 did
not obviously inﬂuence the dynamics of kindling development
under conditions of NMDA receptor inhibition. However,
blocking mGluR5 dramatically slowed the rate of kindling
development exclusively in Fmr1 KO mice. This suggests that
enhanced seizure susceptibility in the Fmr1 KO mouse is at
least partially mediated by abnormal activation of mGluR5-
dependent signal transduction which is largely suppressed in
WT mice. This is consistent with the former ﬁnding that Group
I mGluR and FMRP function in a convergent way in regulating
mRNA translation and subsequently regulate synaptic plasticity
and neuronal excitability (Greenough et al. 2001; Bear et al.
2004; Chuang et al. 2005; Hou et al. 2006; Nosyreva and Huber
2006; Pan and Broadie 2007; Pan et al. 2008).
The development of kindling in Fmr1 KO mice have 3
interesting characteristics: normal EST, accelerated develop-
ment of kindling, and prolonged electrographic seizures. These
features share strong similarity to those observed in a2A
adrenergic receptor (a2A-AR) null mice in which the number
of stimulations required to achieve full kindling is reduced by
about half and the duration of AD is nearly doubled throughout
the development of kindling compared with WT mice
(Janumpalli et al. 1998). The a2A-AR is coupled to Gi/o subset
of heterotrimeric G-proteins, which may function against the
activation of group I mGluRs which interact with Gq proteins.
It is possible that loss of FMRP and inactivation of a2A --AR may
lead to epileptogenesis by allowing excessive activation of
a common signaling cascade. On the other hand, it is possible
that the 2 mutants display similar phenotype of accelerated
kindling by employing 2 parallel cellular cascades.
The formation of new synaptic connections is an important
process in epileptogenesis. MFS is a major hallmark of abnormal
synapseformationthatoccursintheepilepticbrain(Margerison
and Corsellis 1966; McNamara 1999). As FMRP has been shown
to effect neuronal elaboration by affecting the function of
cytoskeletal proteins (Comery et al. 1997; Irwin et al. 2000;
Galvez et al. 2003; Pan et al. 2004; Antar et al. 2006), we
investigated MFS in naive and kindled Fmr1 KO mice. Whereas,
the naive Fmr1 KO brain exhibited no obvious abnormalities in
mossy ﬁber innervation, MFS was dramatically enhanced in the
IML region of Fmr1 KO mice compared with WT mice 5 or 28
weeksafter22dailystimulations(Fig.7).Thisdifferencewasnot
likely to be simply the result of enhanced seizure activity in the
Fmr1 KO brain because WT mice could be stimulated an
additional 8 times (thus 36% more stimulations than Fmr1 KO
mice) and still show little evidence of increased MFS (data not
show). Because no obvious neuronal cell death was detected in
either the kindled WT or Fmr1 KO mice 24 h after the
completion of kindling development, this enhanced axon
reorganization indicates that FMRP may exert an important role
in preventing activity-induced neuronal network reorganization
in the adult brain.
It has long been known that the cellular and molecular
changes that underlie kindling are opposed by refractory
periods, but the nature of these changes are not clear (Mucha
and Pinel 1977). The upregulation of FMRP expression by
kindling-induced seizure as well as the accelerated develop-
ment of kindling and pervasive seizure-evoked synaptogenesis
in Fmr1 KO mice that we observed together support the idea
that FMRP is an important intrinsic buffer against epilepto-
genesis. It is in this light that we predict that the enhanced
susceptibility of patients with FXS to epilepsy is the direct
consequence of the absence of a critical homeostatic factor
that mitigates vulnerability to excessive neuronal excitation.
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